This model explains the observed increase in erythrocyte fragility and subsequent abnormal erythrocyte morphology, decreased lifespan, and anemia in both Rac1−/−Rac2−/− and Hem1−/− erythrocytes. This evidence concerns the gene RAC1 and anemia.